Good morning, healthcare professional.
Happy New Year. As we enter 2026, pharmacy faces regulatory reform, technology innovation, clinical expansion, and economic pressure. Pharmacies that anticipate these shifts will thrive.
We consulted industry analysts, association leaders, and technology innovators to identify defining trends. From GLP-1 evolution to AI-powered tools and evolving reimbursement models, here's what to expect.
In today's 2026 outlook:
- Five trends defining pharmacy practice in 2026
- Key drug launches and patent expirations to prepare for
- Reimbursement landscape forecast for independent pharmacies
- Technology investments delivering highest ROI
GLP-1 Market Matures: From Supply Crisis to Standard of Care
Bottom Line: Manufacturing capacity catches up with demand in 2026, shifting focus from supply management to clinical integration. Pharmacies positioning as GLP-1 clinical experts will capture dispensing volume and service revenue.
Manufacturing capacity catches up with demand in 2026, shifting the GLP-1 conversation from supply management to clinical integration. Develop patient monitoring protocols, adherence support programs, and counseling capabilities specific to GLP-1 therapies. Pharmacies positioning as clinical experts will capture both dispensing volume and service revenue.
AI Transforms Pharmacy Operations: Practical Applications Arrive
Bottom Line: 2026 brings AI from buzzword to practical tool in community pharmacy. Pharmacies benefiting most will approach AI as an efficiency multiplier rather than awaiting perfect solutions.
2026 brings AI from buzzword to practical tool in community pharmacy. Expect AI-powered inventory optimization predicting demand more accurately than traditional algorithms, clinical decision support reducing alert fatigue by learning pharmacist override patterns, and automated patient communication personalizing outreach based on individual adherence patterns. Pharmacies benefiting most will approach AI as an efficiency multiplier.
Reimbursement Models Shift Toward Value-Based Pharmacy
Bottom Line: Several major payers pilot value-based reimbursement tying payment to patient outcomes rather than dispensing volume. Pharmacies building data infrastructure and documentation habits now gain competitive advantage as models scale.
Several major payers pilot value-based pharmacy reimbursement tying payment to patient outcomes rather than product dispensing volume. These models reward adherence improvements, clinical intervention documentation, and demonstrated health outcomes. While fee-for-service remains dominant in 2026, pharmacies building data infrastructure and clinical documentation habits now gain significant competitive advantage as these models scale.
Key Patent Expirations and Drug Launches for 2026
Bottom Line: Notable patent expirations include additional biologics facing biosimilar competition. Pharmacies proactively educating teams on upcoming launches can differentiate with prescribers and patients.
Notable patent expirations in 2026 include additional biologic products facing biosimilar competition, creating formulary management opportunities. Launches include oral GLP-1 formulations, new Alzheimer's disease therapies, and next-generation oncology agents requiring pharmacy teams to invest in product knowledge and patient education capabilities. Pharmacies proactively training staff on upcoming launches can differentiate with prescribers and patients.
The Shortlist
- CMS finalized 2026 Medicare Part B drug payment update, maintaining ASP+6% formula while adding biosimilar incentive payments.
- NCPA released 2026 advocacy agenda, prioritizing federal PBM reform, DIR fee elimination, and pharmacy provider status under Medicare.
- Cardinal Health launched data analytics platform for independent customers, providing benchmarking and profitability insights.
- State pharmacy boards in three states announced reciprocity agreements streamlining multi-state pharmacist licensing.
- CDC updated adult immunization schedule for 2026, adding recommendations expanding pharmacy vaccination opportunities.